S3E17 - Retention in buprenorphine treatment with Albert Burgess-Hull

In this episode, Dr Elle Wadsworth talks to Dr Albert Burgess-Hull, the Scientific Director of SUDx and Head Data Scientist at MATClinics, US. The interview covers a short report examining treatment retention in opioid use disorder comparing subcutaneous injectable versus sublingual buprenorphine. 

·      What is buprenorphine and what it is used for? [01:00]

·      The benefits and drawbacks of sublingual versus subcutaneous injectable buprenorphine [01:38]

·      An overview of the study [04:41]

·      Statistically matching sublingual buprenorphine patients with subcutaneous injectable buprenorphine patients [06:05]

·      The main findings of the study [08:34]

·      The contrast of Albert’s findings with findings in previous literature...